B-cell deficiency does not abrogate development of cutaneous hyperplasia in mice inheriting the defective fibrillin-1 gene

KN Kasturi, A Hatakeyama, C Murai, R Gordon… - Journal of …, 1997 - Elsevier
KN Kasturi, A Hatakeyama, C Murai, R Gordon, RG Phelps, CA Bona
Journal of autoimmunity, 1997Elsevier
Tight-skin (TSK) mouse, the experimental model for scleroderma, develops cutaneous
hyperplasia, cardiac hypertrophy, pulmonary emphysema and autoimmunity against
scleroderma target autoantigens. The cutaneous hyperplasia is associated with the
accumulation of microfibrils and elastic fibers in the middle and deep dermis. Fibrillin-1 (Fbn-
1) is a major component of the 10–12nm microfibrils found in the extracellular matrix. In this
study we report the identification of a genetic marker in the Fbn-1 gene that can distinguish …
Tight-skin (TSK) mouse, the experimental model for scleroderma, develops cutaneous hyperplasia, cardiac hypertrophy, pulmonary emphysema and autoimmunity against scleroderma target autoantigens. The cutaneous hyperplasia is associated with the accumulation of microfibrils and elastic fibers in the middle and deep dermis. Fibrillin-1 (Fbn-1) is a major component of the 10–12nm microfibrils found in the extracellular matrix. In this study we report the identification of a genetic marker in the Fbn-1 gene that can distinguish the mutant phenotype. TSK mice exhibit an unique polymorphism in the Fbn-1 gene. RNA analysis, PCR analysis and sequence determination of the mutant gene showed that the Fbn-1 gene polymorphism is due to intragenic duplication of a segment of the gene coding for 3.0Kb of mRNA sequence (10Kb of the genome). Histological analysis of skin samples from F1 progeny obtained by crossing TSK mice with JH−/−, RAG2−/− or vit/vit showed a significant correlation between the inheritance of the defective Fbn-1 gene and the development of cutaneous hyperplasia. Further, our results also show that in mice deficient in mature B cells inheriting the defective Fbn-1 gene, development of cutaneous hyperplasia is not abrogated. Thus, production of auto-antibodies or the presence of mature B lymphocytes do not play an integral role in the pathogenesis of cutaneous hyperplasia.
Elsevier